Neoadjuvant PARPi or Chemotherapy in Ovarian Cancer Informs Targeting Effector Treg Cells for Homologous-Recombination-Deficient Tumors [10x scRNA-seq]
Single-cell RNA-seq · human · 67 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart.
- Organism
- Homo sapiens (human)
- Samples
- 67 samples: 66 distinct titles, 1 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumorsCell · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE222556_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA922525. Searching any of these in the dataset finder brings you back here.
How we read this: Read from 67 sample titles: 66 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM6925959 P01_P1-1
- GSM6925960 P01_P2-1
- GSM6925961 P02_M1-1
- GSM6925962 P02_M2-1
- GSM6925963 P02_P2-1
- GSM6925964 P03_M1-1
- GSM6925965 P03_M2-1
- GSM6925966 P04_M1-1
- GSM6925967 P04_M2-1
- GSM6925968 P04_P1-1
- GSM6925969 P04_P1-2
- GSM6925970 P05_M1-1
- GSM6925971 P05_M2-1
- GSM6925972 P06_M1-1
- GSM6925973 P06_P1-1
- GSM6925974 P06_P2-1
- GSM6925975 P07_M1-1
- GSM6925976 P08_M1-1
- GSM6925977 P08_M2-1
- GSM6925978 P08_P1-1
- GSM6925979 P08_P2-1
- GSM6925980 P09_M1-1
- GSM6925981 P09_P2-1
- GSM6925982 P10_P1-1
- GSM6925983 P10_P2-1
- GSM6925984 P11_M1-1
- GSM6925985 P11_M2-1
- GSM6925986 P12_M2-1
- GSM6925987 P12_P1-1
- GSM6925988 P12_P2-1
- GSM6925989 P13_M1-1
- GSM6925990 P13_M2-1
- GSM6925991 P14_P1-1
- GSM6925992 P14_P2-1
- GSM6925993 P15_M1-1
- GSM6925994 P15_M2-1
- GSM6925995 P15_P1-1
- GSM6925996 P16_M1-1
- GSM6925997 P16_M2-1
- GSM6925998 P17_P1-1
+ 27 more — browse all 67 samples with per-sample file links →
- GSE269793 Neoadjuvant PARPi or Chemotherapy in Ovarian Cancer Informs Targeting Effector Treg Cells for Homologous-Recombination-Deficient Tumors [Singleron scRNA-seq] 10 samples shares homologous-recombination-deficient, chemotherapy, neoadjuvant, targeting, scrna-seq, effector, ovarian, informs
- GSE222557 Neoadjuvant PARPi or Chemotherapy in Ovarian Cancer Informs Targeting Effector Treg Cells for Homologous-Recombination-Deficient Tumors 148 samples shares homologous-recombination-deficient, chemotherapy, neoadjuvant, targeting, effector, ovarian, informs
- GSE309004 Molecular determinants of neoadjuvant chemotherapy resistance in breast cancer: An analysis of gene expression and tumor microenvironment 54 samples shares chemotherapy, neoadjuvant
- GSE266577 Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer 48 samples shares chemotherapy, ovarian
- GSE296954 Differentiation of tumor-infiltrating GZMK+ effector memory T cells associates with response to neoadjuvant immunotherapy in head and neck cancer 44 samples shares neoadjuvant, effector
- GSE224392 Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human) 21 samples shares chemotherapy, ovarian
- GSE241908 Transcriptomic profiles of ovarian cancer cells isolated from paired cancer ascites before and after chemotherapy 14 samples shares chemotherapy, ovarian
- GSE205472 A Single-Cell Atlas of HR+ Breast Cancer Reveals the Shifting of the Tumor Microenvironment in Response to Neoadjuvant Chemotherapy 13 samples shares chemotherapy, neoadjuvant
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.